Results 51 to 60 of about 1,515,750 (130)
, 2022 20.500.12530/87858Our objectives were to analyze the use of complementary and alternative medicine (CAM) in cancer patients and to describe the incidence and characteristics of interactions between CAM and antineoplastic agents.
Sanjurjo, María +23 more
core +1 more source
Emetic risk classification and evaluation of the emetogenicity of antineoplastic agents—updated MASCC/ESMO consensus recommendation [PDF]
PURPOSE : Our goal was to identify new anticancer agents approved by the US Food and Drug Administration (FDA) and the European Medical Agency (EMA) since the 2016 MASCC/ESMO antiemetic update and classify their emetic potential. METHODS : The MASCC/ESMO
Jordan, Karin +7 more
core +3 more sources
PurposeSurface wipe sampling for various hazardous agents has been employed in many occupational settings over the years for various reasons such as evaluation of potential dermal exposure and health risk, source determination, quality or cleanliness ...
core
PREVENTING AND MANAGEMENT OF EXTRAVASATION OF ANTINEOPLASTIC AGENTS: SCOPING REVIEW
, 2020 Objective: to identify and synthesize the scientific evidences about the event of extravasation in the administration of antineoplastic chemotherapy, with emphasis on prevention and conduct.
Deborah Franscielle da Fonseca +4 more
core +1 more source
Antineoplastic agents; occupational hazards in hospitals
"Antineoplastic agents are widely used in cancer therapy because they can inhibit growth by disrupting cell division and killing actively growing cells. These agents can also cause health effects among health care workers who work with them. A summary of
core
Spending on Antineoplastic Agents in the United States, 2011-2016 [PDF]
, 2018 PURPOSE:: Recent cancer drug approvals are lauded as being more effective with relatively fewer adverse effects, but these treatments come with a great cost to the US health care system.
Edward C. Li (7942331) +3 more
core +2 more sources
Adherence to oral antineoplastic agents, an overview and meta-analysis
Background The use of oral antineoplastic therapies has accelerated in recent years. Non-supervised administration of oncological therapies introduces uncertainty in regard to adherence.
Fohlin, Helena, Mourath, David
core +1 more source
Low molecular weight heparins as antineoplastic agents.
, 2008 There is an increasing interest in the potential role of low molecular weight heparins (LMWHs) in the management of cancer patients. These antithrombotic agents have generated particular excitement because they have been proved useful in both the ...
SIRAGUSA, Sergio
core +1 more source
, 2020 Patient Safety in the Administration of Antineoplastic Agents and Immunotherapy of oncology treatment: scoping review. This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brazil (CAPES) - Finance Code 001.
Patrícia Peres de Oliveira
core +1 more source
, 2019 Antineoplastični lijekovi ili citostatici su skupina lijekova koji se koriste u svrhu liječenja stanica raka. Otkriven je i opisan veliki broj antineoplastičnih lijekova koji se međusobno razlikuju, a s obzirom na njihov mehanizam djelovanja mogu se ...
Knežević, Monika
core +1 more source